Reaction

Infusion reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 407 reports · 4 co-occurring drugs

As of the last recalculation, Infusion appears in 407 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is VENETOCLAX (PRR 36.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Venetoclax4036.736.8
Trifluridine And Tipiracil524.124.1
Rucaparib317.517.5
Voxelotor716.216.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.